Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rebound insomnia and hypnotic self administration.

T Roehrs1, L Merlotti, F Zorick

  • 1Henry Ford Hospital, Sleep Disorders and Research Center, Detroit, MI 48202.

Psychopharmacology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How representative are insomnia clinical trials?

Sleep medicine·2018
Same author

The status of sleep abnormalities as a diagnostic test for major depressive disorder.

Journal of affective disorders·2014
Same author

Medical comorbidity affects antidepressant treatment response in patients with melancholic depression.

Psychotherapy and psychosomatics·2009
Same author

Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?

Neuroscience letters·2008
Same author

Application of bovine microsatellite markers for genetic diversity analysis of European bison (Bison bonasus).

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2006
Same author

Spin-flip processes and ultrafast magnetization dynamics in Co: Unifying the microscopic and macroscopic view of femtosecond magnetism.

Physical review letters·2006
Same journal

GlyT1 inhibition enhances working memory in the mouse TUNL task and normalizes NMDA antagonist-induced network activity.

Psychopharmacology·2026
Same journal

Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

Psychopharmacology·2026
Same journal

Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

Psychopharmacology·2026
Same journal

Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

Psychopharmacology·2026
Same journal

Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

Psychopharmacology·2026
Same journal

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Psychopharmacology·2026
See all related articles

Rebound insomnia did not increase benzodiazepine hypnotic use in patients. Insomnia patients, however, self-administered pills more often than healthy individuals.

Area of Science:

  • Psychiatry
  • Sleep Medicine
  • Pharmacology

Background:

  • Benzodiazepine hypnotics are commonly prescribed for insomnia.
  • Rebound insomnia is a potential side effect of hypnotic discontinuation.
  • Understanding factors influencing self-administration of hypnotics is crucial for patient safety.

Purpose of the Study:

  • To investigate if induced rebound insomnia increases the likelihood of self-administering a benzodiazepine hypnotic.
  • To compare self-administration behaviors between patients with insomnia and healthy individuals.

Main Methods:

  • Twenty-one participants (25-50 years) were divided into three groups: insomnia with disturbed sleep, insomnia with normal sleep, and healthy controls.
  • Rebound insomnia was induced using subjective and polysomnographic assessments.

Related Experiment Videos

  • Participants' self-administration of a benzodiazepine hypnotic (triazolam 0.25 mg) or placebo was monitored.

    • Main Results:

    • Induced rebound insomnia did not elevate the self-administration of triazolam in any participant group.
    • Healthy controls rarely self-administered pills.
    • Insomnia patients demonstrated higher pill self-administration rates compared to controls, irrespective of whether it was a placebo or active drug.

    Conclusions:

    • Rebound insomnia does not appear to be a primary driver for benzodiazepine hypnotic self-administration.
    • Insomnia patients exhibit a general tendency towards higher self-administration of study pills, suggesting underlying behavioral patterns.
    • Further research is needed to explore the psychological and behavioral factors contributing to hypnotic use in insomnia populations.